Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole-exome and targeted amplicon sequencing of fibroadenomas.

ABSTRACT: Whole-exome and targeted amplicon sequencing of fibroadenomas.

PROVIDER: PRJEB5763 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR453744_1.fastq.gz	Fastqsanger.gz
	ERR453744_2.fastq.gz	Fastqsanger.gz
	ERR453745_1.fastq.gz	Fastqsanger.gz
	ERR453745_2.fastq.gz	Fastqsanger.gz
	ERR453746_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 246

Similar Datasets

Whole exome sequencing data from cholangiocarcinoma

Project description:whole exome sequening

2023-01-05 | GSE220940 | GEO

Whole exome sequencing of Cervical Squamous samples

Project description:The raw data consist of whole exome sequencing data of cervical squamous samples

2022-02-11 | E-MTAB-11407 | biostudies-arrayexpress

Gene expression profiling of breast fibroadenomas

2014-06-13 | GSE55594 | GEO

Amplicon-based targeted re-sequencing analysis of target genes in human DNA samples using the Illumina TruSeq Custom Amplicon technology

Project description:Amplicon-based targeted re-sequencing analysis was performed in the patient-derived gliobastoma cell culture samples. For this purpose, genomic DNA (gDNA) was isolated and DNA libraries were prepared using the TruSeq Custom Amplicon Low Input (Illumina, Inc.) technology. By this, a pool of 375 amplicons was generated for each single sample in order to enrich for the target genes ATRX1, EGFR, IDH1, NF1, PDGFRA, PIK3CG, PIK3R1, PTEN, RB1 and TP53. Sequencing was performed on the Illumina MiSeq® next generation sequencing system (Illumina Inc.) and its 2 x 250 bp paired-end v2 read chemistry. The resulting reads were quality controlled and mapped against the human reference genome (hg19). For all samples, sequence variations of the amplified regions of interest in comparison to the human reference sequence were identified and filtered based on reliability.

2021-07-07 | E-MTAB-9343 | biostudies-arrayexpress

Whole exome sequencing of human primary uveal melanomas

Project description:Primary uveal melanomas show multiple genetic alterations. To determine mutational status of six human primary uveal melanomas, we performed whole exome sequencing (WES) and called Single Nucleotide Polimorphism (SNPs) to identify somatic mutations in these human primary uveal melanomas.

2021-01-25 | GSE138664 | GEO

Whole-exome sequencing

Project description:Whole-exome sequencing unveils the genomic features in micropapillary lung adenocarcinoma

| PRJEB70310 | ENA

Targeted amplicon sequencing data from specified genomic amplicons

Project description:Purpose: The goals of this study are to introduce a new genome editing tool, which has the higher editing scope than the original genome editing tools. Methods: First, we transfected PE2 (the original prime editing tool, prime editor2), PE3 (the original prime editing tool, prime editor3) and HOPE (the new tool we developed in this study) vectors into human cells, respectively. Then, we harvested the genomic DNA form the transfected cells and amplified the specified amplicons. Finally, we used targeted amplicon sequencing approach to compare the editing efficiency and presion of the new tool with the original reported tools. Results: Our new genome editing tool improves the editing efficiency of prime editing without increasing the risk of undesired indels formation. Conclusions: We deleveped a new genome editing tool to increase the likelihood of successful gene engineering.

2021-04-10 | GSE171470 | GEO

Whole Exome Sequencing of two non-obstructive azoospermia patients

Project description:We collected blood samples of two non-obstructive azoospermia patients, and performed whole exome sequencing to explore the causal mutations for male infertility.

2021-06-22 | E-MTAB-9287 | biostudies-arrayexpress

Gene expression profiling of breast fibroadenomas

Project description:Fibroadenomas are the most common benign breast tumors in women under 30. Unlike their malignant counterparts, relatively molecular profiling has been done on fibroadenomas. Here we performed gene expression profiling on ten fibroadenomas in order to better characterize these tumors. Through targeted amplicon sequencing, we have found that six of these tumors have MED12 mutations. Here, we show that the MED12 mutations, among others, are associated with activated estrogen signaling, as well as increased invasiveness through upregulation of ECM remodelling genes. Microarray gene expression profiling was performed on 10 breast fibroadenomas and a combination of unsupervised and supervised clustering was performed to determine any differentially activated pathways between samples with mutated and non-mutated MED12.

2014-06-13 | E-GEOD-55594 | biostudies-arrayexpress

Genotyping by whole-exome sequencing of human with hereditary pheochromocytoma

Project description:Whole exome sequencing identification of Max mutations and further validation in pheochromocytoma patients

2012-03-01 | E-MTAB-591 | biostudies-arrayexpress